Brenden Johnson, B.S.

Research Fellow
UPMC Children's Hospital of Pittsburgh

Poster(s):

• Identifying ERK5 and its Associated Protein Interactome as Novel Druggable Targets in Diffuse Midline Glioma, H3K27-altered.
  Friday, May 3, 2024